Company had a strong start to 2025, emerging as an R&D-focused organization
Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
Seeking Alpha / 1 hour ago 1 Views
Seeking Alpha / 1 hour ago 1 Views
Company had a strong start to 2025, emerging as an R&D-focused organization
Comments